Tyrosine kinase inhibitors and cancer therapy.
Madhusudan
Srinivasan
S
Cancer Research UK, Medical Oncology Unit, The Churchill Hospital, Oxford, UK.
Ganesan
Trivadi S
TS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015195:Drug Design; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D047428:Protein Kinase Inhibitors / Q000145:classification / Q000627:therapeutic use* / Q000633:toxicity; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000502:physiology
D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases